Skip to main content

CENTERSPACE (IRET) Prévisions des stocks 2025 - Prédiction et analyse des prix de l'IA


CENTERSPACE (IRET) Prévisions du cours de l'action AI et analyse des investissements

CENTERSPACE Graphique du cours de l'action et analyse technique

Chargement CENTERSPACE graphique interactif des prix et analyse technique...

CENTERSPACE (IRET) - Analyse complète des actions et recherche en matière d'investissement

Deep dive into CENTERSPACE's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about CENTERSPACE, including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

Pour CENTERSPACE: CENTERSPACE operates in the Real Estate & Construction sector, making it an emerging small-cap investment.

CENTERSPACE (Symbole boursier: IRET) est une entreprise leader dans le secteur Real Estate & Construction. , opérant spécifiquement dans le secteur Real Estate Investment Trusts..

L'organisation emploie environ 392 professionnels dans le monde entier. .

L'entreprise s'est imposée comme une opportunité d'investissement émergente avec un potentiel de croissance substantiel.

Understanding Financial Performance

Ce que signifient ces indicateurs: Key financial indicators showing CENTERSPACE's revenue scale, profitability, market value, and shareholder returns.

Comment les lire: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

Pour CENTERSPACE: With $258M in annual revenue and -5,6% net margin, the company demonstrates developing profitability.

Recettes annuelles: $258 millions d'euros générer une -5,6% marge bénéficiaire nette .

Capitalisation boursière: $317 millions d'euros - Classé comme investissement en petites capitalisations offrant un fort potentiel de croissance.

Rendement des fonds propres (ROE): 10,4% - Supérieure à la moyenne l'efficacité du rendement de l'actionnaire, indiquant domaines d'amélioration opérationnelle.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for CENTERSPACE stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.

Pour CENTERSPACE: Unlock premium access to view detailed AI predictions and price targets.

🚀 Débloquer les prédictions Premium de l'IA pour accéder à nos prévisions avancées d'apprentissage automatique pour l'action CENTERSPACE, y compris des objectifs de prix à 7, 30 et 90 jours avec des intervalles de confiance et des évaluations de risque.

Understanding Market Position

What this analysis covers: CENTERSPACE's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

Pour CENTERSPACE: Strong free cash flow generation demonstrates developing operational efficiency.

L'entreprise CENTERSPACE est stratégiquement compétitive dans le secteur très dynamique de l'industrie automobile. Real Estate Investment Trusts marché, représentant un investissement émergent de petite capitalisation avec un potentiel de croissance substantiel et des capacités de perturbation du marché .

L'entreprise fait preuve d'une grande efficacité opérationnelle en générant un flux de trésorerie disponible d'un montant annuel de __65 millions de dollars., complétée par une impressionnante 24,9% croissance des flux de trésorerie d'une année sur l'autre.

L'entreprise conserve une marge brute -1,7% saine, ce qui témoigne d'un pouvoir de fixation des prix et d'une efficacité opérationnelle solides.

CENTERSPACE (IRET) Analyse fondamentale et données sur les délits d'initiés (Rapports financiers trimestriels)

Données financières trimestrielles complètes, tendances en matière de bénéfices, transactions d'initiés et participations institutionnelles pour CENTERSPACE analyse des actions.

Chargement CENTERSPACE analyse fondamentale complète et données sur les délits d'initiés...

Plongez au cœur de la santé financière de CENTERSPACE, de ses indicateurs de valorisation et de son efficacité opérationnelle pour prendre des décisions d'investissement éclairées.

Comprendre les paramètres d'évaluation

Ce que signifient ces indicateurs: Les indicateurs de valorisation permettent de déterminer si le prix de l'action CENTERSPACE est juste par rapport à ses bénéfices, ses actifs et sa position sur le marché.

Comment les lire: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

Pour CENTERSPACE: Avec un ratio P/E de 16,69, le marché valorise modérément les bénéfices de l'entreprise.

P/E Ratio 16,69x
P/B Ratio 0,50x
Market Cap $317M
Dividend Yield 0,07%
EPS $-1,58
Valeur comptable/action $38,05
Recettes/actions $0,23
FCF/action $3,93
Comprendre les indicateurs de rentabilité

Ce que signifient ces indicateurs: Ces ratios mesurent l'efficacité avec laquelle CENTERSPACE convertit les revenus en profits et génère des bénéfices pour les actionnaires.

Comment les lire: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

Pour CENTERSPACE: Un ROE de 10,4% montre bien création de valeur pour l'actionnaire.

ROE 10,4%
ROA 3,6%
ROIC 6,1%
Gross Margin -1,7%
Operating Margin 6,2%
Net Margin -5,6%
EBT Margin 34,9%
Comprendre les indicateurs de santé financière

Ce que signifient ces indicateurs: Ces ratios évaluent la capacité de CENTERSPACE à faire face à ses obligations à court terme et à gérer efficacement ses niveaux d'endettement.

Comment les lire: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

Pour CENTERSPACE: Un ratio de liquidité générale de 0,63_. suggère des problèmes potentiels de liquidité.

Current Ratio 0,63x
Quick Ratio 0,59x
D/E Ratio 1,33x
Financial Leverage 2,75x
Interest Coverage 3,0x
Working Capital $37M
Comprendre les indicateurs de flux de trésorerie

Ce que signifient ces indicateurs: Les indicateurs de flux de trésorerie révèlent la capacité de CENTERSPACE à générer des liquidités à partir de ses activités et à financer ses initiatives de croissance.

Comment les lire: Il est essentiel de disposer d'un flux de trésorerie d'exploitation positif. Le flux de trésorerie disponible indique l'argent disponible pour les dividendes, les rachats ou les investissements.

Pour CENTERSPACE: Flux de trésorerie disponible de $65M offre une certaine flexibilité pour les rendements des actionnaires et les investissements de croissance.

Operating Cash Flow $65M
Free Cash Flow $65M
Capital Spending $-142M
OCF Growth YoY 24,9%
FCF Growth YoY 24,9%
FCF/Sales 36,6%
CapEx/Sales 58,6%
Comprendre les mesures d'efficacité opérationnelle

Ce que signifient ces indicateurs: Ces ratios mesurent l'efficacité avec laquelle CENTERSPACE utilise ses actifs et gère son fonds de roulement.

Comment les lire: Des taux de rotation plus élevés indiquent une utilisation efficace des actifs. Des délais de recouvrement plus courts témoignent d'une gestion efficace du crédit.

Pour CENTERSPACE: Une rotation des actifs de 0,12x laisse entrevoir des possibilités d'amélioration dans les domaines suivants utilisation des actifs.

Asset Turnover 0,12x
Receivables Turnover 172,4x
Fixed Assets Turnover 189,3x
Jours de vente en souffrance 2 jours
Comprendre les données des états financiers

Ce que signifient ces indicateurs: Chiffres clés du compte de résultat et du bilan de CENTERSPACE montrant la performance financière absolue.

Comment les lire: Les recettes montrent l'ampleur de l'entreprise, tandis que les marges indiquent la rentabilité. Les postes du bilan révèlent la structure financière.

Pour CENTERSPACE: Avec un chiffre d'affaires annuel de 258M$, CENTERSPACE démontrer la solidité de la taille de l'entreprise.

Compte de résultat ($ Millions d'euros)
Recettes totales $258M
Revenu d'exploitation $16M
Revenu net $-14M
Frais de vente et d'administration $11M
Coût des marchandises vendues $9M
Faits marquants du bilan (% Of Assets)
Total Current Assets 3%
Cash & Short-term Investments 1%
Total Liabilities 54%
Short-term Debt 2%
Accounts Receivable 1%
Informations sur les dividendes et les actionnaires
Dividends Per Share $1,48
Payout Ratio -0,9%
Shares Outstanding 17M
Indicateurs de croissance (en glissement annuel)
EPS Growth -7,8%

Dernières nouvelles CENTERSPACE Actualités boursières et analyses de marché

Dernières nouvelles, rapports d'analystes et mises à jour du marché concernant le cours de l'action CENTERSPACE (IRET) et les perspectives d'investissement.

, source: Business Insider

Centerspace (NYSE:CSR) has observed the following analyst ratings within the last quarter: These 4 analysts have an average price target of $64.0 versus the current price of Centerspace at $50.83 ...

, source: Nasdaq

Centerspace (NYSE:CSR) is gearing up to announce its quarterly earnings on Monday, 2024-10-28. Here's a quick overview of what investors should know before the release. Analysts are estimating ...

CENTERSPACE Concurrents et analyse des pairs - Real Estate & Construction Secteur

Analyse comparative de CENTERSPACE par rapport à ses pairs et à ses concurrents dans le secteur Real Estate & Construction, avec des prévisions alimentées par l'IA et des indicateurs financiers clés.

Entreprise Symbole du téléscripteur Prévisions AI à 90 jours Capitalisation boursière (en millions d'USD) Ratio P/E Rapport P/B
AAT Unlock Forecast - 30 Days FREE Trial $1499M 15,9x 1,3x
ABR Unlock Forecast - 30 Days FREE Trial $2590M 12,1x 0,9x
ABR-PD Unlock Forecast - 30 Days FREE Trial $3979M 18,6x 1,3x
ABR-PE Unlock Forecast - 30 Days FREE Trial $3935M 18,4x 1,3x
ABR-PF Unlock Forecast - 30 Days FREE Trial $4866M 22,8x 1,6x
ACR Unlock Forecast - 30 Days FREE Trial $159M 7,3x 0,4x
ACRE Unlock Forecast - 30 Days FREE Trial $282M 8,5x 0,5x
ACR-PC Unlock Forecast - 30 Days FREE Trial $191M 8,8x 0,5x
ACR-PD Unlock Forecast - 30 Days FREE Trial $167M 7,7x 0,4x
ADC Unlock Forecast - 30 Days FREE Trial $8037M 43,3x 1,4x
ADC-PA Unlock Forecast - 30 Days FREE Trial $2010M 10,8x 0,4x
AGNC Unlock Forecast - 30 Days FREE Trial $10771M 28,5x 1,0x
AGNCL Unlock Forecast - 30 Days FREE Trial $26376M 69,8x 2,6x
AGNCM Unlock Forecast - 30 Days FREE Trial $26043M 68,9x 2,5x
AGNCN Unlock Forecast - 30 Days FREE Trial $26824M 71,0x 2,6x
AGNCO Unlock Forecast - 30 Days FREE Trial $26688M 70,6x 2,6x
AGNCP Unlock Forecast - 30 Days FREE Trial $26230M 69,4x 2,5x
AHR Unlock Forecast - 30 Days FREE Trial $6933M x 2,9x
AHT Unlock Forecast - 30 Days FREE Trial $19M -1,5x -0,1x
AHT-PD Unlock Forecast - 30 Days FREE Trial $54M x x
AHT-PF Unlock Forecast - 30 Days FREE Trial $45M x x
AHT-PG Unlock Forecast - 30 Days FREE Trial $51M x x
AHT-PH Unlock Forecast - 30 Days FREE Trial $45M x x
AHT-PI Unlock Forecast - 30 Days FREE Trial $45M x x
AIV Unlock Forecast - 30 Days FREE Trial $3249M -6,0x 35,5x
AJX Unlock Forecast - 30 Days FREE Trial $133M -0,8x 0,5x
AKR Unlock Forecast - 30 Days FREE Trial $2429M 470,2x 1,1x
ALEX Unlock Forecast - 30 Days FREE Trial $1367M 17,5x 1,4x
ALX Unlock Forecast - 30 Days FREE Trial $1218M 32,6x 8,4x
AMH Unlock Forecast - 30 Days FREE Trial $332M 39,2x 0,1x
AMT Unlock Forecast - 30 Days FREE Trial $257435M 199,1x 69,3x
APLE Unlock Forecast - 30 Days FREE Trial $3048M 16,8x 1,0x
ARE Unlock Forecast - 30 Days FREE Trial $18049M 55,8x 1,1x
ARI Unlock Forecast - 30 Days FREE Trial $1529M -9,0x 0,8x
ARR Unlock Forecast - 30 Days FREE Trial $1379M -6,0x 0,8x
ARR-PC Unlock Forecast - 30 Days FREE Trial $1909M x 1,2x
AVB Unlock Forecast - 30 Days FREE Trial $28417M 24,5x 2,4x
BDN Unlock Forecast - 30 Days FREE Trial $764M -5,2x 0,9x
BFS Unlock Forecast - 30 Days FREE Trial $1204M 28,0x 3,7x
BFS-PD Unlock Forecast - 30 Days FREE Trial $826M 19,2x 2,6x
BFS-PE Unlock Forecast - 30 Days FREE Trial $870M 20,2x 2,7x
BHM Unlock Forecast - 30 Days FREE Trial $227M 83,0x 1,7x
BHR Unlock Forecast - 30 Days FREE Trial $597M -3,1x 2,7x
BHR-PB Unlock Forecast - 30 Days FREE Trial $3269M x 14,5x
BHR-PD Unlock Forecast - 30 Days FREE Trial $4058M x 18,0x
BMNM Unlock Forecast - 30 Days FREE Trial $14M x 0,6x
BNL Unlock Forecast - 30 Days FREE Trial $3814M 38,6x 1,3x
BRSP Unlock Forecast - 30 Days FREE Trial $751M -6,6x 0,8x
BRT Unlock Forecast - 30 Days FREE Trial $282M -37,6x 1,5x
BRX Unlock Forecast - 30 Days FREE Trial $8544M 25,5x 2,9x
BXMT Unlock Forecast - 30 Days FREE Trial $3301M -17,4x 0,9x
BXP Unlock Forecast - 30 Days FREE Trial $17162M 3477,7x 3,3x
CBL Unlock Forecast - 30 Days FREE Trial $950M 14,5x 3,3x
CCI Unlock Forecast - 30 Days FREE Trial $46333M 36,6x 6,1x
CDP Unlock Forecast - 30 Days FREE Trial $3615M 24,1x 2,4x
CDR-PB Unlock Forecast - 30 Days FREE Trial $244M 44,3x 10,9x
CDR-PC Unlock Forecast - 30 Days FREE Trial $220M 39,8x 9,8x
CHCT Unlock Forecast - 30 Days FREE Trial $443M -220,9x 1,0x
CHMI Unlock Forecast - 30 Days FREE Trial $106M -9,3x 0,5x
CHMI-PA Unlock Forecast - 30 Days FREE Trial $842M x 3,7x
CHMI-PB Unlock Forecast - 30 Days FREE Trial $882M x 3,8x
CHTH Unlock Forecast - 30 Days FREE Trial $603M x 0,9x
CIM Unlock Forecast - 30 Days FREE Trial $1195M 6,2x 0,5x
CIMN Unlock Forecast - 30 Days FREE Trial $2081M 10,8x 0,8x
CIMO Unlock Forecast - 30 Days FREE Trial $2091M 10,9x 0,8x
CIM-PA Unlock Forecast - 30 Days FREE Trial $1862M 9,7x 0,7x
CIM-PB Unlock Forecast - 30 Days FREE Trial $2005M 10,4x 0,8x
CIM-PC Unlock Forecast - 30 Days FREE Trial $1915M 9,9x 0,7x
CIM-PD Unlock Forecast - 30 Days FREE Trial $1995M 10,4x 0,8x
CIO Unlock Forecast - 30 Days FREE Trial $280M -15,4x 0,5x
CIO-PA Unlock Forecast - 30 Days FREE Trial $1010M x 1,6x
CLDT Unlock Forecast - 30 Days FREE Trial $388M 41,0x 0,5x
CLDT-PA Unlock Forecast - 30 Days FREE Trial $1101M 116,5x 1,5x
CLPR Unlock Forecast - 30 Days FREE Trial $73M -10,4x -20,5x
CMCT Unlock Forecast - 30 Days FREE Trial $6M -0,1x 0,0x
CMRF Unlock Forecast - 30 Days FREE Trial $1241M x 0,7x
COLD Unlock Forecast - 30 Days FREE Trial $3902M -26,5x 1,3x
CPT Unlock Forecast - 30 Days FREE Trial $12319M 79,0x 2,7x
CSR Unlock Forecast - 30 Days FREE Trial $1189M -74,6x 1,7x
CTO Unlock Forecast - 30 Days FREE Trial $574M 41,8x 1,0x
CTO-PA Unlock Forecast - 30 Days FREE Trial $730M x 1,3x
CTRE Unlock Forecast - 30 Days FREE Trial $6938M 31,6x 2,1x
CUBE Unlock Forecast - 30 Days FREE Trial $9688M 25,9x 3,4x
CUZ Unlock Forecast - 30 Days FREE Trial $4927M 81,8x 1,0x
CXW Unlock Forecast - 30 Days FREE Trial $2189M 21,0x 1,5x
DEA Unlock Forecast - 30 Days FREE Trial $1029M 65,3x 0,8x
DEI Unlock Forecast - 30 Days FREE Trial $4888M 129,7x 2,4x
DHC Unlock Forecast - 30 Days FREE Trial $1033M -1,7x 0,6x
DHCNI Unlock Forecast - 30 Days FREE Trial $4225M -10,4x 2,3x
DHCNL Unlock Forecast - 30 Days FREE Trial $3981M x 2,0x
DLR Unlock Forecast - 30 Days FREE Trial $61435M 44,4x 2,7x
DLR-PJ Unlock Forecast - 30 Days FREE Trial $8355M 6,0x 0,4x
DLR-PK Unlock Forecast - 30 Days FREE Trial $9314M 6,7x 0,4x
DLR-PL Unlock Forecast - 30 Days FREE Trial $8104M 5,9x 0,4x
DOC Unlock Forecast - 30 Days FREE Trial $13637M 82,7x 1,7x
DRH Unlock Forecast - 30 Days FREE Trial $1764M 26,0x 1,1x
DRH-PA Unlock Forecast - 30 Days FREE Trial $5413M 79,8x 3,4x
DTLAP Unlock Forecast - 30 Days FREE Trial $0M x x
DX Unlock Forecast - 30 Days FREE Trial $1376M 41,8x 1,8x
DX-PC Unlock Forecast - 30 Days FREE Trial $M x x
EARN Unlock Forecast - 30 Days FREE Trial $212M -11,6x 0,9x
EGP Unlock Forecast - 30 Days FREE Trial $8798M 37,2x 2,6x
ELME Unlock Forecast - 30 Days FREE Trial $1514M -114,5x 1,5x
ELS Unlock Forecast - 30 Days FREE Trial $12921M 25,8x 7,5x
EPR Unlock Forecast - 30 Days FREE Trial $0M 18,4x 0,0x
EPR-PC Unlock Forecast - 30 Days FREE Trial $M x x
EPR-PE Unlock Forecast - 30 Days FREE Trial $M x x
EPR-PG Unlock Forecast - 30 Days FREE Trial $M x x
EPRT Unlock Forecast - 30 Days FREE Trial $6048M 27,0x 1,6x
EQC Unlock Forecast - 30 Days FREE Trial $177M 2,3x 0,1x
EQIX Unlock Forecast - 30 Days FREE Trial $76495M 77,0x 5,4x
EQR Unlock Forecast - 30 Days FREE Trial $25472M 28,0x 2,3x
ESRT Unlock Forecast - 30 Days FREE Trial $0M 52,3x 0,0x
ESS Unlock Forecast - 30 Days FREE Trial $17941M 22,4x 3,2x
EXR Unlock Forecast - 30 Days FREE Trial $32727M 33,5x 2,4x
FBRT Unlock Forecast - 30 Days FREE Trial $1025M 9,4x 0,7x
FBRT-PE Unlock Forecast - 30 Days FREE Trial $1885M 17,2x 1,3x
FCPT Unlock Forecast - 30 Days FREE Trial $2656M 25,1x 1,8x
FPI Unlock Forecast - 30 Days FREE Trial $521M 53,4x 0,8x
FR Unlock Forecast - 30 Days FREE Trial $7141M 26,3x 2,7x
FREVS Unlock Forecast - 30 Days FREE Trial $0M 0,0x 0,0x
FRT Unlock Forecast - 30 Days FREE Trial $9463M 27,3x 2,9x
FRT-PC Unlock Forecast - 30 Days FREE Trial $1959M 5,7x 0,6x
FSP Unlock Forecast - 30 Days FREE Trial $174M -1,9x 0,3x
FVR Unlock Forecast - 30 Days FREE Trial $508M x 1,4x
GIPR Unlock Forecast - 30 Days FREE Trial $-118M -0,8x 17,0x
GIPRW Unlock Forecast - 30 Days FREE Trial $1M x 0,2x
GLPI Unlock Forecast - 30 Days FREE Trial $14744M 20,5x 3,2x
GMRE Unlock Forecast - 30 Days FREE Trial $527M 51,2x 1,1x
GMRE-PA Unlock Forecast - 30 Days FREE Trial $1761M 171,1x 3,5x
GNL Unlock Forecast - 30 Days FREE Trial $1622M -4,5x 0,9x
GPMT Unlock Forecast - 30 Days FREE Trial $146M -0,9x 0,3x
GPMT-PA Unlock Forecast - 30 Days FREE Trial $985M x 1,7x
GRP-UN Unlock Forecast - 30 Days FREE Trial $2657M x 3,0x
HHH Unlock Forecast - 30 Days FREE Trial $3476M -4,8x 1,3x
HIW Unlock Forecast - 30 Days FREE Trial $3611M 27,5x 1,5x
HR Unlock Forecast - 30 Days FREE Trial $5686M -11,5x 1,1x
HST Unlock Forecast - 30 Days FREE Trial $12405M 18,8x 1,9x
HTIA Unlock Forecast - 30 Days FREE Trial $414M -7,6x 0,6x
HTIBP Unlock Forecast - 30 Days FREE Trial $405M -7,3x 0,6x
ICRP Unlock Forecast - 30 Days FREE Trial $81M 7,2x 0,3x
ICR-PA Unlock Forecast - 30 Days FREE Trial $196M 17,3x 0,8x
IHT Unlock Forecast - 30 Days FREE Trial $2M -57,7x 0,6x
ILPT Unlock Forecast - 30 Days FREE Trial $744M -2,3x 1,4x
IMPM Unlock Forecast - 30 Days FREE Trial $2M x x
INN Unlock Forecast - 30 Days FREE Trial $903M 104,9x 1,0x
INN-PE Unlock Forecast - 30 Days FREE Trial $3414M 396,4x 3,8x
INN-PF Unlock Forecast - 30 Days FREE Trial $3372M 391,5x 3,8x
IOR Unlock Forecast - 30 Days FREE Trial $75M 12,5x 0,6x
IRET Unlock Forecast - 30 Days FREE Trial $317M 16,7x 0,5x
IRM Unlock Forecast - 30 Days FREE Trial $29130M 202,7x -41,7x
IRT Unlock Forecast - 30 Days FREE Trial $4340M 156,4x 1,3x
IVR Unlock Forecast - 30 Days FREE Trial $529M 13,1x 0,8x
IVR-PC Unlock Forecast - 30 Days FREE Trial $1632M 40,3x 2,3x
IVT Unlock Forecast - 30 Days FREE Trial $2300M 20,5x 1,3x
JBGS Unlock Forecast - 30 Days FREE Trial $1327M -11,3x 0,7x
KBSR Unlock Forecast - 30 Days FREE Trial $21M x 0,1x
KIM Unlock Forecast - 30 Days FREE Trial $15426M 25,8x 1,5x
KIM-PL Unlock Forecast - 30 Days FREE Trial $14826M 24,8x 1,4x
KIM-PM Unlock Forecast - 30 Days FREE Trial $15178M 25,4x 1,4x
KIM-PN Unlock Forecast - 30 Days FREE Trial $41959M 70,2x 4,0x
KRC Unlock Forecast - 30 Days FREE Trial $5280M 24,1x 1,0x
KREF Unlock Forecast - 30 Days FREE Trial $700M 952,5x 0,6x
KREF-PA Unlock Forecast - 30 Days FREE Trial $1409M x 1,1x
KRG Unlock Forecast - 30 Days FREE Trial $5176M 27,7x 1,6x
LADR Unlock Forecast - 30 Days FREE Trial $0M 15,1x 0,0x
LAMR Unlock Forecast - 30 Days FREE Trial $13106M 29,8x 14,5x
LAND Unlock Forecast - 30 Days FREE Trial $373M -54,4x 0,5x
LANDM Unlock Forecast - 30 Days FREE Trial $900M -119,7x 1,3x
LANDO Unlock Forecast - 30 Days FREE Trial $723M -104,0x 1,1x
LANDP Unlock Forecast - 30 Days FREE Trial $722M -103,5x 1,1x
LFT Unlock Forecast - 30 Days FREE Trial $122M 8,6x 0,5x
LFT-PA Unlock Forecast - 30 Days FREE Trial $1131M 79,4x 4,9x
LINE Unlock Forecast - 30 Days FREE Trial $10676M x 1,2x
LOAN Unlock Forecast - 30 Days FREE Trial $62M 11,2x 1,4x
LTC Unlock Forecast - 30 Days FREE Trial $1838M 22,1x 1,9x
LXP Unlock Forecast - 30 Days FREE Trial $2709M 31,0x 1,3x
LXP-PC Unlock Forecast - 30 Days FREE Trial $14076M 160,9x 6,8x
MAA Unlock Forecast - 30 Days FREE Trial $17613M 30,8x 3,0x
MAA-PI Unlock Forecast - 30 Days FREE Trial $6948M 12,2x 1,2x
MAC Unlock Forecast - 30 Days FREE Trial $4827M -64,7x 1,9x
MDRR Unlock Forecast - 30 Days FREE Trial $15M -8,9x 1,1x
MDRRP Unlock Forecast - 30 Days FREE Trial $28M -16,5x 2,3x
MDV Unlock Forecast - 30 Days FREE Trial $219M -24,6x 1,3x
MDV-PA Unlock Forecast - 30 Days FREE Trial $364M x 2,2x
MFA Unlock Forecast - 30 Days FREE Trial $1089M 8,5x 0,6x
MFAN Unlock Forecast - 30 Days FREE Trial $2651M 20,6x 1,5x
MFAO Unlock Forecast - 30 Days FREE Trial $2662M 20,7x 1,5x
MFA-PB Unlock Forecast - 30 Days FREE Trial $2288M 17,8x 1,3x
MFA-PC Unlock Forecast - 30 Days FREE Trial $2552M 19,9x 1,4x
MITN Unlock Forecast - 30 Days FREE Trial $757M 16,3x 1,4x
MITP Unlock Forecast - 30 Days FREE Trial $753M 16,2x 1,4x
MITT Unlock Forecast - 30 Days FREE Trial $232M 5,0x 0,4x
MITT-PA Unlock Forecast - 30 Days FREE Trial $685M 14,8x 1,3x
MITT-PB Unlock Forecast - 30 Days FREE Trial $672M 14,5x 1,3x
MITT-PC Unlock Forecast - 30 Days FREE Trial $750M 16,2x 1,4x
MKZR Unlock Forecast - 30 Days FREE Trial $133M x 2,0x
MPW Unlock Forecast - 30 Days FREE Trial $2719M -1,3x 0,6x
NHHS Unlock Forecast - 30 Days FREE Trial $340M 3,0x 1,4x
NHI Unlock Forecast - 30 Days FREE Trial $3682M 25,8x 2,5x
NHPAP Unlock Forecast - 30 Days FREE Trial $452M x 0,7x
NHPBP Unlock Forecast - 30 Days FREE Trial $454M x 0,7x
NLCP Unlock Forecast - 30 Days FREE Trial $292M 11,2x 0,7x
NLOP Unlock Forecast - 30 Days FREE Trial $439M x 0,9x
NLY Unlock Forecast - 30 Days FREE Trial $13285M -22,9x 1,0x
NNN Unlock Forecast - 30 Days FREE Trial $8095M 20,6x 1,9x
NREF Unlock Forecast - 30 Days FREE Trial $269M -28,2x 2,5x
NREF-PA Unlock Forecast - 30 Days FREE Trial $M x x
NSA Unlock Forecast - 30 Days FREE Trial $2861M 26,1x 2,8x
NTST Unlock Forecast - 30 Days FREE Trial $1549M 1247,7x 1,2x
NXDT Unlock Forecast - 30 Days FREE Trial $181M -1,9x 0,2x
NXDT-PA Unlock Forecast - 30 Days FREE Trial $681M x 0,9x
NXRT Unlock Forecast - 30 Days FREE Trial $880M 16,6x 2,5x
NYC Unlock Forecast - 30 Days FREE Trial $35M -0,1x 0,5x
NYMT Unlock Forecast - 30 Days FREE Trial $684M 11,0x 0,5x
NYMTG Unlock Forecast - 30 Days FREE Trial $2313M 37,2x 1,7x
NYMTI Unlock Forecast - 30 Days FREE Trial $2322M 37,4x 1,7x
NYMTL Unlock Forecast - 30 Days FREE Trial $2059M 33,1x 1,5x
NYMTM Unlock Forecast - 30 Days FREE Trial $2315M 37,3x 1,7x
NYMTN Unlock Forecast - 30 Days FREE Trial $2003M 32,2x 1,5x
NYMTZ Unlock Forecast - 30 Days FREE Trial $1660M 26,7x 1,2x
O Unlock Forecast - 30 Days FREE Trial $54683M 59,7x 1,4x
OHI Unlock Forecast - 30 Days FREE Trial $10939M 27,3x 2,3x
OLP Unlock Forecast - 30 Days FREE Trial $501M 25,4x 1,7x
ONL Unlock Forecast - 30 Days FREE Trial $170M -2,5x 0,2x
ORC Unlock Forecast - 30 Days FREE Trial $911M 142,2x 1,0x
OUT Unlock Forecast - 30 Days FREE Trial $4003M 37,2x 7,4x
PCH Unlock Forecast - 30 Days FREE Trial $3331M 80,0x 1,7x
PCOK Unlock Forecast - 30 Days FREE Trial $180M x 5,5x
PEB Unlock Forecast - 30 Days FREE Trial $1400M -21,5x 0,5x
PEB-PE Unlock Forecast - 30 Days FREE Trial $2468M x 0,9x
PEB-PF Unlock Forecast - 30 Days FREE Trial $2532M x 1,0x
PEB-PG Unlock Forecast - 30 Days FREE Trial $2464M x 0,9x
PEB-PH Unlock Forecast - 30 Days FREE Trial $2230M x 0,8x
PECO Unlock Forecast - 30 Days FREE Trial $5626M 81,7x 2,5x
PGRE Unlock Forecast - 30 Days FREE Trial $1392M -5,8x 0,5x
PINE Unlock Forecast - 30 Days FREE Trial $265M 169,3x 1,2x
PKST Unlock Forecast - 30 Days FREE Trial $518M -3,7x 0,7x
PLD Unlock Forecast - 30 Days FREE Trial $116289M 33,7x 2,2x
PLDGP Unlock Forecast - 30 Days FREE Trial $58098M 16,9x 1,1x
PLYM Unlock Forecast - 30 Days FREE Trial $705M 59,5x 1,2x
PMT Unlock Forecast - 30 Days FREE Trial $1079M 10,3x 0,6x
PMT-PA Unlock Forecast - 30 Days FREE Trial $2111M 20,1x 1,1x
PMT-PB Unlock Forecast - 30 Days FREE Trial $2094M 19,9x 1,1x
PMT-PC Unlock Forecast - 30 Days FREE Trial $1630M 15,5x 0,9x
PMTU Unlock Forecast - 30 Days FREE Trial $2221M 21,1x 1,2x
PMTV Unlock Forecast - 30 Days FREE Trial $2213M 21,0x 1,2x
PMTW Unlock Forecast - 30 Days FREE Trial $2206M 21,0x 1,2x
PSA Unlock Forecast - 30 Days FREE Trial $51604M 28,5x 5,5x
PSA-PF Unlock Forecast - 30 Days FREE Trial $3883M 2,1x 0,4x
PSA-PG Unlock Forecast - 30 Days FREE Trial $3791M 2,1x 0,4x
PSA-PH Unlock Forecast - 30 Days FREE Trial $4228M 2,3x 0,5x
PSA-PI Unlock Forecast - 30 Days FREE Trial $3583M 2,0x 0,4x
PSA-PJ Unlock Forecast - 30 Days FREE Trial $3469M 1,9x 0,4x
PSA-PK Unlock Forecast - 30 Days FREE Trial $3552M 2,0x 0,4x
PSA-PL Unlock Forecast - 30 Days FREE Trial $3421M 1,9x 0,4x
PSA-PM Unlock Forecast - 30 Days FREE Trial $3052M 1,7x 0,3x
PSA-PN Unlock Forecast - 30 Days FREE Trial $2864M 1,6x 0,3x
PSA-PO Unlock Forecast - 30 Days FREE Trial $2883M 1,6x 0,3x
PSA-PP Unlock Forecast - 30 Days FREE Trial $2953M 1,6x 0,3x
PSA-PQ Unlock Forecast - 30 Days FREE Trial $2903M 1,6x 0,3x
PSA-PR Unlock Forecast - 30 Days FREE Trial $2955M 1,6x 0,3x
PSA-PS Unlock Forecast - 30 Days FREE Trial $3031M 1,7x 0,3x
PSTL Unlock Forecast - 30 Days FREE Trial $0M 147,2x 0,0x
PW Unlock Forecast - 30 Days FREE Trial $3M -0,2x 0,6x
PW-PA Unlock Forecast - 30 Days FREE Trial $13M x 2,1x
RC Unlock Forecast - 30 Days FREE Trial $769M -13,0x 0,4x
RCB Unlock Forecast - 30 Days FREE Trial $4373M -44,3x 2,4x
RCC Unlock Forecast - 30 Days FREE Trial $4448M -45,2x 2,4x
RCD Unlock Forecast - 30 Days FREE Trial $4253M x 2,3x
RC-PC Unlock Forecast - 30 Days FREE Trial $2970M x 1,6x
RC-PE Unlock Forecast - 30 Days FREE Trial $2848M x 1,6x
REFI Unlock Forecast - 30 Days FREE Trial $279M 8,1x 0,9x
REG Unlock Forecast - 30 Days FREE Trial $13312M 22,1x 2,0x
REGCO Unlock Forecast - 30 Days FREE Trial $4284M x 0,6x
REGCP Unlock Forecast - 30 Days FREE Trial $4392M x 0,7x
REXR Unlock Forecast - 30 Days FREE Trial $10585M 33,3x 1,2x
REXR-PB Unlock Forecast - 30 Days FREE Trial $5664M 17,8x 0,6x
REXR-PC Unlock Forecast - 30 Days FREE Trial $5650M 17,8x 0,6x
RHP Unlock Forecast - 30 Days FREE Trial $10080M 37,7x 12,6x
RITM Unlock Forecast - 30 Days FREE Trial $6987M 8,7x 0,9x
RITM-PA Unlock Forecast - 30 Days FREE Trial $14226M 17,7x 1,8x
RITM-PB Unlock Forecast - 30 Days FREE Trial $14226M 17,7x 1,8x
RITM-PC Unlock Forecast - 30 Days FREE Trial $13952M 17,4x 1,8x
RITM-PD Unlock Forecast - 30 Days FREE Trial $13746M 17,1x 1,7x
RLJ Unlock Forecast - 30 Days FREE Trial $1158M 20,0x 0,5x
RLJ-PA Unlock Forecast - 30 Days FREE Trial $3755M 65,0x 1,7x
ROIC Unlock Forecast - 30 Days FREE Trial $2248M 45,7x 1,7x
RPT Unlock Forecast - 30 Days FREE Trial $129M -0,8x 0,4x
RWT Unlock Forecast - 30 Days FREE Trial $17M 31,3x 0,0x
RWTN Unlock Forecast - 30 Days FREE Trial $70M x 0,1x
RWTO Unlock Forecast - 30 Days FREE Trial $69M x 0,1x
RWTP Unlock Forecast - 30 Days FREE Trial $69M x 0,1x
RYN Unlock Forecast - 30 Days FREE Trial $3676M 36,4x 1,9x
SACC Unlock Forecast - 30 Days FREE Trial $1174M 370,5x 5,3x
SACH Unlock Forecast - 30 Days FREE Trial $54M 21,3x 0,3x
SAFE Unlock Forecast - 30 Days FREE Trial $1189M 11,6x 0,5x
SBAC Unlock Forecast - 30 Days FREE Trial $20400M 23,2x -5,1x
SBRA Unlock Forecast - 30 Days FREE Trial $4619M 25,3x 1,7x
SCCC Unlock Forecast - 30 Days FREE Trial $1183M 361,5x 6,6x
SCCD Unlock Forecast - 30 Days FREE Trial $1029M 304,5x 5,7x
SCCE Unlock Forecast - 30 Days FREE Trial $923M 304,8x 5,1x
SCCF Unlock Forecast - 30 Days FREE Trial $907M 279,9x 5,1x
SCCG Unlock Forecast - 30 Days FREE Trial $911M 325,2x 5,1x
SELF Unlock Forecast - 30 Days FREE Trial $60M 24,0x 1,3x
SEVN Unlock Forecast - 30 Days FREE Trial $163M 10,5x 0,6x
SILA Unlock Forecast - 30 Days FREE Trial $1360M x 1,0x
SITC Unlock Forecast - 30 Days FREE Trial $495M 1,4x 1,0x
SKT Unlock Forecast - 30 Days FREE Trial $4084M 38,7x 6,4x
SLG Unlock Forecast - 30 Days FREE Trial $4965M -33,2x 1,3x
SLG-PI Unlock Forecast - 30 Days FREE Trial $1889M x 0,5x
SOHO Unlock Forecast - 30 Days FREE Trial $18M -1,4x 0,4x
SOHOB Unlock Forecast - 30 Days FREE Trial $322M -21,4x 7,0x
SOHON Unlock Forecast - 30 Days FREE Trial $335M -21,8x 7,3x
SOHOO Unlock Forecast - 30 Days FREE Trial $333M -25,6x 7,2x
SPG Unlock Forecast - 30 Days FREE Trial $142M 23,1x 0,1x
SQFT Unlock Forecast - 30 Days FREE Trial $64M 1,2x 1,8x
SQFTP Unlock Forecast - 30 Days FREE Trial $191M 24,7x 5,4x
SQFTW Unlock Forecast - 30 Days FREE Trial $0M x 0,0x
STAG Unlock Forecast - 30 Days FREE Trial $6992M 29,9x 2,0x
STLY Unlock Forecast - 30 Days FREE Trial $20M 32,3x 0,5x
STRW Unlock Forecast - 30 Days FREE Trial $663M 111,4x 42,8x
STSR Unlock Forecast - 30 Days FREE Trial $28M x 0,4x
STWD Unlock Forecast - 30 Days FREE Trial $7822M 21,2x 1,2x
SUI Unlock Forecast - 30 Days FREE Trial $17312M 13,5x 2,3x
SUNS Unlock Forecast - 30 Days FREE Trial $145M 14,5x 0,8x
SVC Unlock Forecast - 30 Days FREE Trial $481M -2,2x 0,7x
TCI Unlock Forecast - 30 Days FREE Trial $412M 62,5x 0,5x
TFSA Unlock Forecast - 30 Days FREE Trial $202M x 0,0x
TPTA Unlock Forecast - 30 Days FREE Trial $563M x 3,3x
TRTX Unlock Forecast - 30 Days FREE Trial $790M 11,8x 0,7x
TRTX-PC Unlock Forecast - 30 Days FREE Trial $1477M 22,0x 1,4x
TWO Unlock Forecast - 30 Days FREE Trial $1289M -55,6x 0,6x
TWOD Unlock Forecast - 30 Days FREE Trial $M x x
TWO-PA Unlock Forecast - 30 Days FREE Trial $M x x
TWO-PB Unlock Forecast - 30 Days FREE Trial $M x x
TWO-PC Unlock Forecast - 30 Days FREE Trial $M x x
UDR Unlock Forecast - 30 Days FREE Trial $16657M 126,2x 5,0x
UHT Unlock Forecast - 30 Days FREE Trial $574M 32,0x 3,5x
UMH Unlock Forecast - 30 Days FREE Trial $1287M 42,2x 1,4x
UMH-PD Unlock Forecast - 30 Days FREE Trial $1924M 63,1x 2,1x
UNIT Unlock Forecast - 30 Days FREE Trial $1760M 49,9x -0,5x
VICI Unlock Forecast - 30 Days FREE Trial $35547M 12,9x 1,3x
VNO Unlock Forecast - 30 Days FREE Trial $9411M 10,8x 1,5x
VNO-PL Unlock Forecast - 30 Days FREE Trial $4291M 4,9x 0,7x
VNO-PM Unlock Forecast - 30 Days FREE Trial $4233M 4,8x 0,7x
VNO-PN Unlock Forecast - 30 Days FREE Trial $4226M 4,8x 0,7x
VNO-PO Unlock Forecast - 30 Days FREE Trial $3528M 4,0x 0,6x
VNORP Unlock Forecast - 30 Days FREE Trial $12723M 14,5x 2,1x
VRE Unlock Forecast - 30 Days FREE Trial $1849M -32,8x 1,7x
VTR Unlock Forecast - 30 Days FREE Trial $32061M 167,7x 2,8x
WELL Unlock Forecast - 30 Days FREE Trial $114326M 101,2x 3,2x
WHLR Unlock Forecast - 30 Days FREE Trial $-9M -4,1x -0,7x
WHLRD Unlock Forecast - 30 Days FREE Trial $-193M -86,0x -4,8x
WHLRL Unlock Forecast - 30 Days FREE Trial $-774M -344,1x -21,2x
WHLRP Unlock Forecast - 30 Days FREE Trial $-22M -9,8x -0,6x
WPC Unlock Forecast - 30 Days FREE Trial $14991M 44,7x 1,8x
WSR Unlock Forecast - 30 Days FREE Trial $693M 20,6x 1,6x
WY Unlock Forecast - 30 Days FREE Trial $18327M 65,7x 1,9x

Questions fréquemment posées - CENTERSPACE Prévisions des stocks

Quelle est la précision des prévisions boursières de CENTERSPACE ?

Our AI model demonstrates 8% historical accuracy for IRET predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

Quels sont les facteurs qui influencent les prévisions de prix des actions ?

Notre analyse prend en compte les indicateurs financiers de CENTERSPACE, les tendances sectorielles de Real Estate & Construction, le sentiment du marché, les indicateurs techniques, les données sur les bénéfices et les facteurs macroéconomiques qui influent sur la performance des actions.

Est-ce que CENTERSPACE est un bon investissement en 2025 ?

D'après notre analyse de l'IA, CENTERSPACE montre potentiel pour différents scénarios de marché. Tenez compte de votre tolérance au risque, de votre calendrier d'investissement et de la diversification de votre portefeuille avant de prendre des décisions d'investissement.

A quelle fréquence les prévisions CENTERSPACE sont-elles mises à jour ?

Les prévisions boursières sont mises à jour quotidiennement à l'aide de données de marché en temps réel, ce qui vous permet de recevoir les prévisions et les informations d'investissement les plus récentes grâce à l'IA.

Vous voulez une analyse CENTERSPACE plus avancée ?

Déverrouillez les fonctionnalités premium, y compris les objectifs de prix détaillés, les évaluations de risque, l'optimisation du portefeuille et les alertes en temps réel pour l'action CENTERSPACE.

Mon portefeuille

Tableau de bord des investissements

Chargement de votre portefeuille...